Theophylline

   
Google
 
Web NewDrugInformation.com

Theophylline


Drug - Theophylline
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Theophylline
Multiple ingredients are in alphabetical order.

Strength - 200MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.

Applicant - PLIVA
The firm name holding legal responsibility for Theophylline. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089808
The FDA assigned number to Theophylline. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Theophylline. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 30, 1990
The date Theophylline was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Theophylline. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Theophylline is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pliva Inc
The full name of the firm holding legal responsibility for the new application of Theophylline.

Theophylline